Drug Shortage Report for TARO-ZOLEDRONIC ACID CONCENTRATE
Report ID | 105088 |
Drug Identification Number | 02415186 |
Brand name | TARO-ZOLEDRONIC ACID CONCENTRATE |
Common or Proper name | ZOLEDRONIC ACID CONCENTRATE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ZOLEDRONIC ACID |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ml |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-31 |
Estimated end date | 2020-02-21 |
Actual end date | 2020-02-11 |
Shortage status | Resolved |
Updated date | 2020-02-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-24 | French | Compare |
v3 | 2020-02-24 | English | Compare |
v2 | 2020-02-02 | French | Compare |
v1 | 2020-02-02 | English | Compare |
Showing 1 to 4 of 4